Terms: = Gastric cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1
29630 results:
1. Regulation of the
Gu P; Huang W; Lu W; Shu P
Discov Med; 2024 May; 36(184):923-935. PubMed ID: 38798252
[TBL] [Abstract] [Full Text] [Related]
2. Multi-cancer risk stratification based on national health data: a retrospective modelling and validation study.
Jung AW; Holm PC; Gaurav K; Hjaltelin JX; Placido D; Mortensen LH; Birney E; Brunak SR; Gerstung M
Lancet Digit Health; 2024 Jun; 6(6):e396-e406. PubMed ID: 38789140
[TBL] [Abstract] [Full Text] [Related]
3. Immunohistochemical Human Epidermal Growth Factor Receptor 2 (HER2) Expression Pattern in gastric Adenocarcinomas in a Nigerian Tertiary Hospital.
Mashor MI; Ezenkwa US; Ogun GO; Ajani MA; Ogunbiyi JO
West Afr J Med; 2024 Mar; 41(3):311-316. PubMed ID: 38788150
[TBL] [Abstract] [Full Text] [Related]
4. Induction of Hepatoma Cell Pyroptosis by Endogenous Lipid Geranylgeranoic Acid-A Comparison with Palmitic Acid and Retinoic Acid.
Shidoji Y
Cells; 2024 May; 13(10):. PubMed ID: 38786033
[TBL] [Abstract] [Full Text] [Related]
5. Clinical value of serum polyunsaturated fatty acids in patients with gastric polyps.
Li N; Qian Q; Ouyang J; Hu M; Liu J; Wu H; Shi R; Zheng S
PeerJ; 2024; 12():e17413. PubMed ID: 38784403
[TBL] [Abstract] [Full Text] [Related]
6. Retrospective Study of Claudin 18 Isoform 2 Prevalence and Prognostic Association in gastric and Gastroesophageal Junction Adenocarcinoma.
Waters R; Sewastjanow-Silva M; Yamashita K; Abdelhakeem A; Iwata KK; Moran D; Elsouda D; Guerrero A; Pizzi M; Vicentini ER; Shanbhag N; Ta A; Chatterjee D; Ajani JA
JCO Precis Oncol; 2024 May; 8():e2300543. PubMed ID: 38781542
[TBL] [Abstract] [Full Text] [Related]
7. [Safety of patients undergoing radical resection combined with paclitaxel-based hyperthermic intraperitoneal chemotherapy for locally advanced gastric cancer].
Mei JX; Zhao LY; Zhang WH; Liu K; Chen XL; Yang K; Hu JK
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):471-477. PubMed ID: 38778687
[No Abstract] [Full Text] [Related]
8. [Clinicopathological features and prognosis of early-onset gastric cancer: a large-scale retrospective real-world study].
Liu JD; Yang CL; Jin PL; Li BS; Zhao JJ; Li HJ; Wang XF; Sun YH
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 May; 27(5):452-456. PubMed ID: 38778684
[No Abstract] [Full Text] [Related]
9. Enhancing surgical outcomes in elderly gastric cancer patients: the role of comprehensive preoperative assessment and support.
Ushimaru Y; Nagano S; Kawabata R; Nishikawa K; Takeoka T; Kitagawa A; Ohara N; Tomihara H; Maeda S; Imasato M; Noura S; Miyamoto A
World J Surg Oncol; 2024 May; 22(1):136. PubMed ID: 38778314
[TBL] [Abstract] [Full Text] [Related]
10. Influence of cachexia on immunotherapy efficacy and prognosis for malignant tumors of the digestive system.
Tao Z; Chen Z; Gao Y; Quan M
Cancer Rep (Hoboken); 2024 May; 7(5):e2100. PubMed ID: 38775250
[TBL] [Abstract] [Full Text] [Related]
11. Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors.
Xing N; Liu J; Hou L; Zhao Y; Ma H; Wang F; Guo Z
Front Immunol; 2024; 15():1381061. PubMed ID: 38774877
[TBL] [Abstract] [Full Text] [Related]
12. Untargeted metabolomics in gastric and colorectal cancer patients - preliminary results.
Kaźmierczak-Siedlecka K; Muszyński D; Styburski D; Makarewicz J; Sobocki BK; Ulasiński P; Połom K; Stachowska E; Skonieczna-Żydecka K; Kalinowski L
Front Cell Infect Microbiol; 2024; 14():1394038. PubMed ID: 38774628
[TBL] [Abstract] [Full Text] [Related]
13. Stomach cancer Prediction Model (SCoPM): An approach to risk stratification in a diverse U.S. population.
Wu BU; Dong EY; Chen Q; Luong TQ; Lustigova E; Jeon CY; Chen W
PLoS One; 2024; 19(5):e0303153. PubMed ID: 38771811
[TBL] [Abstract] [Full Text] [Related]
14. Evaluating nomogram models for predicting survival outcomes in gastric gastrointestinal stromal tumors with SEER database analysis.
Yong L; Li L; Wu J; Liang P; Gao J
Sci Rep; 2024 May; 14(1):11494. PubMed ID: 38769376
[TBL] [Abstract] [Full Text] [Related]
15. Impact of the number of therapy lines on survival in advanced gastric and esophagogastric adenocarcinoma - a real-world retrospective analysis from Croatia.
Bišof V; Katić A; Soče M; Vidović M; Viculin J; Pleština S; Vrdoljak E
Neoplasma; 2024 Apr; 71(2):201-208. PubMed ID: 38766850
[TBL] [Abstract] [Full Text] [Related]
16. cancer survival in sub-Saharan Africa (SURVCAN-3): a population-based study.
Joko-Fru WY; Bardot A; Bukirwa P; Amidou S; N'da G; Woldetsadik E; Chesumbai G; Korir A; Kamaté B; Koon M; Hansen R; Finesse A; Somdyala N; Chokunonga E; Chigonzoh T; Liu B; Kantelhardt EJ; Parkin DM; Soerjomataram I
Lancet Glob Health; 2024 Jun; 12(6):e947-e959. PubMed ID: 38762297
[TBL] [Abstract] [Full Text] [Related]
17. Genome-wide investigation of lncRNAs revealed their tight association with gastric cancer.
Liu T; Ma Y; Han S; Sun P
J Cancer Res Clin Oncol; 2024 May; 150(5):261. PubMed ID: 38761291
[TBL] [Abstract] [Full Text] [Related]
18. Immunotherapy combined with apatinib in the treatment of advanced or metastatic gastric/gastroesophageal tumors: a systematic review and meta-analysis.
Wang J; Lin J; Wang R; Tong T; Zhao Y
BMC Cancer; 2024 May; 24(1):603. PubMed ID: 38760737
[TBL] [Abstract] [Full Text] [Related]
19. Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study.
Deng R; Wu J; Li D; Wu B; Shi R; Tian Y; Yao J; Wang LS
BMC Gastroenterol; 2024 May; 24(1):170. PubMed ID: 38760726
[TBL] [Abstract] [Full Text] [Related]
20. Hyponutrition among newly diagnosed gastric cancer.
Pham VT; Nguyen MLT; Pham C; LE QV; Tran DH; LE TS; Nguyen LT; Bui KC
Bratisl Lek Listy; 2024; 125(6):392-398. PubMed ID: 38757598
[TBL] [Abstract] [Full Text] [Related]
[Next]